Re: Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma

2018 ◽  
Vol 200 (6) ◽  
pp. 1378-1379
Author(s):  
Wenbin Xue ◽  
Lu Yang ◽  
Qiang Wei
Keyword(s):  
High Risk ◽  
Neoadjuvant Chemotherapy ◽  
Urothelial Carcinoma ◽  
Upper Tract Urothelial Carcinoma ◽  
Pathological Stage ◽  
Upper Tract

scholarly journals Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice

2021 ◽  
Author(s):  
Georges Abi Tayeh ◽  
Nour Khalil ◽  
Marwan Alkassis ◽  
Fouad Aoun ◽  
Chady Waked ◽  
...  
Keyword(s):  
Clinical Practice ◽  
High Risk ◽  
Neoadjuvant Chemotherapy ◽  
Urothelial Carcinoma ◽  
Radical Cystectomy ◽  
Surgical Management ◽  
Narrative Review ◽  
Upper Tract Urothelial Carcinoma ◽  
Upper Tract ◽  
Intravesical Instillations

The COVID-19 pandemic has modified the management of urothelial carcinoma (UC). Eighteen months after the onset of the pandemic, a scoping narrative review was able to state that radical cystectomy for UC should not be delayed beyond 10 weeks when neoadjuvant chemotherapy (NAC) was administered and 12 weeks when it was not. NAC should be considered when imminent chemotherapy cannot be performed. Early cystectomy should not be delayed when indicated for patients with high-risk non-MIBC. Patients with non-MIBC should still receive their induction doses of intravesical instillations. Diagnostic cystoscopy should not be deferred in symptomatic patients. Surgical management of upper tract urothelial carcinoma (UTUC) allows for a wider deferral interval.

scholarly journals Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma

2020 ◽  
Author(s):  
Kenji Zennami ◽  
Makoto Sumitomo ◽  
Kiyoshi Takahara ◽  
Takuhisa Nukaya ◽  
Masashi Takenaka ◽  
...  
Keyword(s):  
High Risk ◽  
Neoadjuvant Chemotherapy ◽  
Urothelial Carcinoma ◽  
Upper Tract Urothelial Carcinoma ◽  
Upper Tract

Oncologic surveillance for surgically-treated high risk upper tract urothelial carcinoma

2021 ◽  
Vol 79 ◽  
pp. S1105-S1106
Author(s):  
A. Martini ◽  
C. Lonati ◽  
A. Necchi ◽  
A. Briganti ◽  
F. Montorsi ◽  
...  
Keyword(s):  
High Risk ◽  
Urothelial Carcinoma ◽  
Upper Tract Urothelial Carcinoma ◽  
Upper Tract
Sign in / Sign up

Export Citation Format

Share Document